Skip to main content
. 2014 May 2;12(5):2539–2589. doi: 10.3390/md12052539

Table 4.

BACE1 inhibitors.

Compound/organism IC50 (μM)
Xestosaprol D/sponge Xestospongia sp. 93.2 [72]
Xestosaprol F/sponge Xestospongia sp. 135.0 [69]
Xestosaprol G/sponge Xestospongia sp. 155.0 [69]
Xestosaprol H/sponge Xestospongia sp. 82.0 [69]
Xestosaprol I/sponge Xestospongia sp. 163.0 [69]
Xestosaprol J/sponge Xestospongia sp. 90.0 [69]
Xestosaprol K/sponge Xestospongia sp. 93.0 [69]
Xestosaprol L/sponge Xestospongia sp. 98.0 [69]
Xestosaprol M/sponge Xestospongia sp. 104.0 [69]
Dictyodendrin F/sponge Ianthella sp. 1.5 [74]
Dictyodendrin H/sponge Ianthella sp. 1.0 [74]
Dictyodendrin I/sponge Ianthella sp. 2.0 [74]
Dictyodendrin J/sponge Ianthella sp. 2.0 [74]
Dictazole A/sponge Smenospongia cerebriformis Duchassaing and Michelotti 135.0 [71]
Topsentinol K trisulfate/sponge Topsentia sp. 1.2 [70]
Lamellarin O/sponge Ianthella sp. 40% (at 10 μM) [73]
Lamellarin O1/sponge Ianthella sp. 60% (at 10 μM) [73]
Lamellarin O2/sponge Ianthella sp. 40% (at 10 μM) [73]
Ianthellidone F/sponge Ianthella sp. 40% (at 10 μM) [73]